BOSTON SCIENTIFIC CORP

BSX

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0001225208-26-003178
Filing date: Mar 4, 2026
Earliest execution date: Mar 2, 2026

Summary

Type

Neutral

Net shares

+879

% of shares

100.00%

Amount (USD)

$0

Insider confidence score

90.0 out of 100

Positive

  • Massive buy (≥10% of shares)

Negative

  • Minimal buy amount (<$10K)

Stock transactions

Transaction 1

Security

Common Stock

Action

Grant

Date

2026-03-02

Code

A

Net shares

+556.0

Acquired/Disposed

Acquired

Shares Owned Before

0.0

Shares Owned After

556.0

Transaction 2

Security

Common Stock

Action

Grant

Date

2026-03-02

Code

A

Net shares

+323.0

Acquired/Disposed

Acquired

Shares Owned Before

556.0

Shares Owned After

879.0

Filing's footnotes

1. Grant of restricted stock to non-employee director following initial appointment to the Board of Directors, which, pursuant to the Company's non-employee director compensation program, has been prorated for the time period from the effective date of the appointment to the date of the Company's 2026 annual meeting of stockholders. The grant of restricted stock vests in full upon the next annual meeting of stockholders. Reflects a value of approximately $42,419.50 (representing 100% of the prorated amount of the non-employee director compensation program's annual equity award having a value of $215,000) divided by the closing price of common stock on the date of grant.

2. Grant of restricted stock in lieu of 100% yearly cash compensation, following initial appointment to the Board of Directors, which, pursuant to the Company's non-employee director compensation program, has been prorated for the time period from the effective date of the appointment to the date of the Company's 2026 annual meeting of stockholders. Reflects a value of approximately $24,662.50 (representing 100% of the prorated amount of the non-employee director compensation program's cash retainer having a value of $125,000) divided by the closing price of the common stock on the date of grant.

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.